A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis.

Translated title of the contribution: A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis.

D.W. Hommes, W. Erkelens, C. Ponsioen, P. Stokkers, E. Rauws, M. van der Spek, F.J.W. ten Kate, S.J.H. van Deventer

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionA double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis.
Original languageUndefined/Unknown
Pages (from-to)522-526
Number of pages5
JournalJournal of Clinical Pathology
Volume42
Issue number5
Publication statusPublished - 2008

Cite this